These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 628351)

  • 21. Pancreatic A-cell function in the partially pancreatectomized Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.
    Zhu M; Mizuno A; Noma Y; Sano T; Shima K
    Metabolism; 1996 Nov; 45(11):1360-7. PubMed ID: 8931640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma glucagon immunoreactivity in a totally pancreatectomized patient.
    Villanueva ML; Hedo JA; Marco J
    Diabetologia; 1976 Dec; 12(6):613-6. PubMed ID: 1001850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin and glucagon breakthrough of somatostatin suppression: importance of portal vein hormone measurements.
    Polonsky K; Jaspan J; Pugh W; Dhorajiwala J; Abraham M; Blix P; Moossa AR
    Diabetes; 1981 Aug; 30(8):664-9. PubMed ID: 6114006
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoreactive glucagon responses to arginine in three pancreatectomized humans.
    Palmer JP; Werner PL; Benson JW; Ensinck JW
    Metabolism; 1976 Nov; 25(11 Suppl 1):1483-5. PubMed ID: 979653
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapancreatic glucagon in the dog.
    Vranic M; Engerman R; Doi K; Morita S; Yip CC
    Metabolism; 1976 Nov; 25(11 Suppl 1):1469-73. PubMed ID: 979650
    [No Abstract]   [Full Text] [Related]  

  • 28. Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.
    Cherrington AD; Kawamori R; Pek S; Vranic M
    Diabetes; 1974 Oct; 23(10):805-15. PubMed ID: 4422477
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
    Kåresen R; Tronier B; Aune S
    Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastrointestinal glucagons. -- their secretions and roles].
    Matsuyama T
    Horumon To Rinsho; 1983 Apr; 31(4):297-309. PubMed ID: 6136352
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Diabetes without glucagon.
    Lancet; 1976 Apr; 1(7964):855-6. PubMed ID: 56667
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).
    Santeusanio F; Massi-Benedetti M; Angeletti G; Calabrese G; Bueti A; Brunetti P
    J Endocrinol Invest; 1981; 4(1):93-6. PubMed ID: 7016969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Gastroenterol Jpn; 1980; 15(3):241-6. PubMed ID: 7399222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
    Bonner-Weir S; Trent DF; Weir GC
    J Clin Invest; 1983 Jun; 71(6):1544-53. PubMed ID: 6134752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of somatostatin (SRIF) infusion on glucose homeostasis in newborn lambs: evidence for a significant role of glucagon.
    Sperling MA; Grajwer L; Leake RD; Fisher DA
    Pediatr Res; 1977 Sep; 11(9 Pt 1):962-7. PubMed ID: 904983
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.